GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Future Policy Benefits

Xintela AB (OSTO:XINT) Future Policy Benefits


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Xintela AB Business Description

Traded in Other Exchanges
N/A
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.